Trends in publicly subsidized and private access to GLP‐1 medicines indicated for type 2 diabetes in Australia, 2020–2025

British Journal of Clinical Pharmacology · Published 2026-07-27 · DOI 10.1002/bcp.70715

Free full text

Authors (11)

Michael O. Falster, Juliana de Oliveira Costa, Tamara Y. Milder, Joanne Carson, Cade Shadbolt, Brendon L. Neuen, Clare Arnott, Andrew Wilson, Min Jun, Nicole Pratt, Sallie-Anne Pearson

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Falster, M., Costa, J., Milder, T., et al. (2026). Trends in publicly subsidized and private access to GLP‐1 medicines indicated for type 2 diabetes in Australia, 2020–2025. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70715

Related articles

• Relationships among nitrous oxide exposure, neurological injury and biomarkers · British Journal of Clinical Pharmacology · 2026 · Same journal
• Predicting cognitive function in Alzheimer's clinical trials via amyloid β‐protein biomarkers · British Journal of Clinical Pharmacology · 2026 · Same journal
• Comparative risk of ventricular arrhythmia and sudden cardiac death among acetylcholinesterase inhibitors in dementia: A population‐based cohort study · British Journal of Clinical Pharmacology · 2026 · Same journal
• Pharmacogenomics of dolutegravir: A scoping review of evidence, gaps and clinical implications · British Journal of Clinical Pharmacology · 2026 · Same journal
• MT‐RNR1 genotype testing for preventing aminoglycoside‐mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx) · British Journal of Clinical Pharmacology · 2026 · Same journal
• Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus · British Journal of Clinical Pharmacology · 2026 · Same journal
• Analysis of spontaneous reports of suspected adverse reactions related to medical cannabis from the Italian Phytovigilance System · British Journal of Clinical Pharmacology · 2026 · Same journal
• A university‐certified course on dossier assessment for regulatory scientists in Africa—Reporting on our 5‐year experience · British Journal of Clinical Pharmacology · 2026 · Same journal
• Perceptions of prescribing violations by doctors: A qualitative study using semi‐structured interviews · British Journal of Clinical Pharmacology · 2026 · Same journal
• Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study · British Journal of Clinical Pharmacology · 2026 · Same journal